Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Merck May Buy Smart Cells for More Than $500 Million, WSJ Says

Dec. 1 (Bloomberg) -- Merck & Co. may buy SmartCells Inc., the closely-held biotechnology company that is developing a diabetes treatment, for more than $500 million if certain conditions are met, the Wall Street Journal reported, citing an unidentified person familiar with the situation.

The acquisition may be announced tomorrow, the newspaper said.

Story link: {NSN LCS0EV6K50XU<GO>}

To contact the editor responsible for this story: Jeran Wittenstein at

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.